DOI QR코드

DOI QR Code

DRUG INDUCED GINGIVAL HYPERPLASIA IN TAKAYASU'S ARTERITIS : DENTAL CONSIDERATION

Takayasu's Arteritis 환자에서 약에 의해 유발된 치은 비대

  • Kim, Soo-Hyun (Department of Pediatric Dentistry, College of Dentistry, Yonsei University) ;
  • Choi, Ami (Department of Pediatric Dentistry, College of Dentistry, Yonsei University) ;
  • Song, Je-Seon (Department of Pediatric Dentistry, College of Dentistry, Yonsei University) ;
  • Kim, Seong-Oh (Department of Pediatric Dentistry, College of Dentistry, Yonsei University) ;
  • Choi, Byung-Jai (Department of Pediatric Dentistry, College of Dentistry, Yonsei University) ;
  • Lee, Hyo-Seol (Department of Pediatric Dentistry, College of Dentistry, Yonsei University)
  • 김수현 (연세대학교 치과대학 소아치과학교실) ;
  • 최아미 (연세대학교 치과대학 소아치과학교실) ;
  • 송제선 (연세대학교 치과대학 소아치과학교실) ;
  • 김성오 (연세대학교 치과대학 소아치과학교실) ;
  • 최병재 (연세대학교 치과대학 소아치과학교실) ;
  • 이효설 (연세대학교 치과대학 소아치과학교실)
  • Received : 2013.05.29
  • Accepted : 2013.06.01
  • Published : 2013.06.28

Abstract

Takayasu's arteritis(TA) is commonly known as Aortitis Syndrome, Pulseless disease. Cardiac involvement due to vascular occlusion or stenosis is common in TA, expressed in forms of heart failure, aorta hypertension, alteration of artery or cardiac muscle. In this case, a 9 year old boy was referred to our dental clinic by his cardiology doctor for delayed eruption and gingival hyperplasia on upper incisor. The patient was diagnosed as TA with history of taking Amlodipine, a calcium channel blocker as hypertension medication. He was diagnosed as drug induced gingival hyperplasia. Under taking preventive antibiotic, gingivectomy was done. In case dental treatment of TA patient, dentist should be aware of two possible problems. First is the antibiotic prophylaxis due to the high risk of endocarditis. Second is the possibility of drug induced gingival hyperplasia.

Takayasu's arteritis 환자의 치과 치료 시 침습적인 치과 술식 전 심내막염 가능성을 고려하여 예방적 항생제를 투여한다. 복용 약물에 의해 치은증식이 발생할 수 있으므로 약물의 적용에 관한 의과적 자문이 필요하다.

Keywords

References

  1. Duque C, Silva RC, Santos-Pinto L: Takayasu's arteritis: what should the dentist know? Int J Paediatr Dent 15(2):113-117, 2005. https://doi.org/10.1111/j.1365-263X.2005.00598.x
  2. Al-Aghbari K, Al-Motarreb A, Askar F: Takayasu’s Arteritis Associated with Tuberculosis in a Young Yemeni Woman. Heart Views 11(3):117-120, 2010. https://doi.org/10.4103/1995-705X.76804
  3. Brunner J, Feldman BM, Tyrrell PN, et al.: Takayasu arteritis in children and adolescents. Rheumatology 49(10):1806-1814, 2010. https://doi.org/10.1093/rheumatology/keq167
  4. Koide K: Takayasu arteritis in Japan. Heart and Vessels 7(1):48-54, 1992. https://doi.org/10.1007/BF01744544
  5. Dabague J, Reyes PA: Takayasu arteritis in Mexico: a 38-year clinical perspective through literature review. International journal of cardiology 54:S103-S109, 1996. https://doi.org/10.1016/0167-5273(96)02586-7
  6. Rosenthal T, Morag B, Itzchak Y: Takayasu arteritis in Israel. Heart and Vessels 7:44-47, 1992. https://doi.org/10.1007/BF01744543
  7. Butler R, Kalkwarf K, Kaldahl W: Drug-induced gingival hyperplasia: phenytoin, cyclosporine, and nifedipine. The Journal of the American Dental Association 114(1):56-60, 1987. https://doi.org/10.14219/jada.archive.1987.0050
  8. Seymour R, Thomason J, Ellis J: The pathogenesis of drug-induced gingival overgrowth. Journal of clinical periodontology 23(3):165-175, 1996. https://doi.org/10.1111/j.1600-051X.1996.tb02072.x
  9. Brown RS, Beaver WT, Bottomley WK: On the mechanism of drug-induced gingival hyperplasia. Journal of oral pathology & medicine 20(5):201-209, 1991. https://doi.org/10.1111/j.1600-0714.1991.tb00419.x
  10. Mehta AV, Chidambaram B, O’Riordan AC: Verapamil-induced gingival hyperplasia in children. American heart journal 124(2):535, 1992. https://doi.org/10.1016/0002-8703(92)90630-E
  11. Woods R, Amerena V, David P: FDI Commission Working Group: antibiotic prophylaxis for infective endocarditis. Int Dent J 44:215-222, 1994.
  12. Dajani AS, Taubert KA, Wilson W, et al.: Prevention of bacterial endocarditis: recommendations by the American Heart Association. Circulation 96(1):358-366, 1997. https://doi.org/10.1161/01.CIR.96.1.358